119 related articles for article (PubMed ID: 16418316)
1. Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans.
Backman D; Monod M; Danielson UH
J Biomol Screen; 2006 Mar; 11(2):165-75. PubMed ID: 16418316
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir.
Dostál J; Brynda J; Hrušková-Heidingsfeldová O; Pachl P; Pichová I; Rezáčová P
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):160-5. PubMed ID: 22146051
[TBL] [Abstract][Full Text] [Related]
3. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
Backman D; Danielson UH
Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
[TBL] [Abstract][Full Text] [Related]
5. Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors.
Calugi C; Guarna A; Trabocchi A
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):936-43. PubMed ID: 22803674
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.
Monod M; Borg-von Zepelin M; Telenti A; Sanglard D
Dermatology; 1999; 198(4):412-4. PubMed ID: 10490300
[No Abstract] [Full Text] [Related]
7. Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology.
Markgren PO; Lindgren MT; Gertow K; Karlsson R; Hämäläinen M; Danielson UH
Anal Biochem; 2001 Apr; 291(2):207-18. PubMed ID: 11401294
[TBL] [Abstract][Full Text] [Related]
8. Tetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening.
Staib P; Lermann U; Blass-Warmuth J; Degel B; Würzner R; Monod M; Schirmeister T; Morschhäuser J
Antimicrob Agents Chemother; 2008 Jan; 52(1):146-56. PubMed ID: 17954688
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors.
Cutfield SM; Dodson EJ; Anderson BF; Moody PC; Marshall CJ; Sullivan PA; Cutfield JF
Structure; 1995 Nov; 3(11):1261-71. PubMed ID: 8591036
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the interaction between HIV-1 protease and inhibitors using optical biosensor technology.
Markgren PO; Hämäläinen M; Danielson UH
Anal Biochem; 2000 Mar; 279(1):71-8. PubMed ID: 10683232
[TBL] [Abstract][Full Text] [Related]
12. Candida albicans secreted aspartyl proteinases.
Hube B
Curr Top Med Mycol; 1996 Dec; 7(1):55-69. PubMed ID: 9504059
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A.
Borelli C; Ruge E; Schaller M; Monod M; Korting HC; Huber R; Maskos K
Proteins; 2007 Aug; 68(3):738-48. PubMed ID: 17510964
[TBL] [Abstract][Full Text] [Related]
14. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
Blanco MT; Hurtado C; Pérez-Giraldo C; Morán FJ; González-Velasco C; Gómez-García AC
Med Mycol; 2003 Apr; 41(2):167-70. PubMed ID: 12964850
[TBL] [Abstract][Full Text] [Related]
15. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors.
Pichová I; Pavlícková L; Dostál J; Dolejsí E; Hrusková-Heidingsfeldová O; Weber J; Ruml T; Soucek M
Eur J Biochem; 2001 May; 268(9):2669-77. PubMed ID: 11322888
[TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A
J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Zn(II) and Mn(II) on catalytic activity of aspartic proteinases from Candida albicans].
Kutyreva MP; Galimzanova RR; Ulakhovich NA; Glushko NI
Biomed Khim; 2007; 53(1):72-85. PubMed ID: 17436687
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A.
Dostál J; Brynda J; Hrusková-Heidingsfeldová O; Sieglová I; Pichová I; Rezácová P
J Struct Biol; 2009 Aug; 167(2):145-52. PubMed ID: 19401235
[TBL] [Abstract][Full Text] [Related]
19. Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling.
Majer F; Pavlícková L; Majer P; Hradilek M; Dolejsí E; Hrusková-Heidingsfeldová O; Pichová I
Biol Chem; 2006 Sep; 387(9):1247-54. PubMed ID: 16972793
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.
Tavanti A; Pardini G; Campa D; Davini P; Lupetti A; Senesi S
J Clin Microbiol; 2004 Oct; 42(10):4726-34. PubMed ID: 15472333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
